Claims for Patent: 6,437,223
✉ Email this page to a colleague
Summary for Patent: 6,437,223
Title: | Inbred maize line 2070BT |
Abstract: | The present invention is drawn to a novel DNA construct comprising an expression cassette having a constitutive promoter which functions in plant cells operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding a Cry 1Ab protein, and a terminator functional in plants and optionally further comprising a second cassette including a promoter which functions in plants operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding for phosphinothricin acetyl transferase, and a terminator functional in plants wherein the two cassettes are transcribed in the same direction. Also provided are transgenic plants, particularly maize plants, having such a construct stably incorporated into their genomes. |
Inventor(s): | Mettler; Irvin J (Richmond, CA), Mies; David (St. Joseph, IL) |
Assignee: | Syngenta Participations AG (Basel, CH) |
Application Number: | 09/289,010 |
Patent Claims: | 1. Seed of maize inbred line 2070Bt having been sited under ATCC Accession No: 203941, where said seed comprises a nucleic acid construct comprising two cassettes, wherein me
first cassette comprises a CaMV 35S constitutive promoter operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding a Cry1Ab protein, and a terminator functional in plants, and the second c comprises a CaMV 35S promoter
which functions in plant cells operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding for phosphinothricin acetyl transferase, and a terminator functional in plants, wherein the two cassettes are transcribed in the
same direction and, wherein the nucleic acid construct is incorporated into the seed's genome on chromosome 8, near position 117, between markers Z1B3 and UMC150a.
2. An isolated seed of claim 1. 3. A maize plant, or parts thereof, of inbred line 2070Bt, seed of said line having bee deposited under ATCC Accession No: 203941, wherein said maize plant comprises a nucleic acid construct comprising two cassettes, wherein the first cassette comprise a CaMV 35S constitutive promoter operably linked to a maize alcohol dehydrogenase intron, a DNA sequence of a gene encoding a Cry1Ab protein, and a terminator functional in plants and the second cassette comprises a CAMV 35S promoter which functions in plant cells operably linked to a m alcohol dehydrogenase intron, a DNA sequence of a gene encoding for phosphinothricin acetyl transferase, and a terminator functional in plants, wherein the two cassettes are transcribed in the same direction and, wherein e nucleic acid construct is incorporated into the seed's genome on chromosome 8, near position 117, between markers Z1B3 and UMC150a. 4. Pollen of the plant of claim 3. 5. An ovule of the plant of claim 3. 6. A maize plant, or parts thereof, having all the genotpic and phenotypic characteristics of a plant of inbred line 203941 Bt, seed of said line having been deposited under ATCC accession No: 203941. |
Details for Patent 6,437,223
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | 06/04/1986 | ⤷ Try a Trial | 2018-03-13 |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | For Injection | 103132 | ⤷ Try a Trial | 2018-03-13 | |
Merck Sharp & Dohme Corp. | INTRON A | interferon alfa-2b | Injection | 103132 | ⤷ Try a Trial | 2018-03-13 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.